Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPA3P6 is a human pseudogene derived from the heterogeneous nuclear ribonucleoprotein A3 gene. Pseudogenes like HNRNPA3P6 are defined by their sequence similarities to protein-coding genes but with disabling mutations that prevent protein expression. While some pseudogenes have regulatory roles as non-coding RNAs, direct biological or disease contributions of HNRNPA3P6 have not been established in the published literature. It is not a receptor, enzyme, transporter, transcription factor, nor a canonical therapeutic target. HNRNPA3P6 is catalogued in major genomics databases (NCBI Gene: 653115, HGNC: 48495, Ensembl: ENSG00000213300). No aliases corresponding to drug targets, mechanisms, or disease relevance have been found. Summary of caveats: - This target is not a receptor, not an enzyme, not a transporter, nor a transcription factor. - It is NOT considered a therapeutic or diagnostic drug target. - There is no evidence for specific biological activities, disease roles, interacting drugs, or use as a biomarker for HNRNPA3P6. - Therefore, it should not be used as the basis for therapeutic targeting or biomarker development. If you intended to refer to a functional member of the heterogeneous nuclear ribonucleoprotein A/B family, such as HNRNPA3, please clarify, as those are protein-coding genes with substantial functional and disease relevance.
None (no known mechanism, as not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 6 (HNRNPA3P6).